TECH
Bio-Techne CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.37B
P/E Ratio
100.96
EPS
$0.53
Beta
1.49
52W High
$72.06
52W Low
$45.86
50-Day MA
$55.03
200-Day MA
$58.10
Dividend Yield
0.58%
Profit Margin
6.67%
Forward P/E
25.91
PEG Ratio
0.71
About Bio-Techne Corp
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.
Fundamentals
| Revenue (TTM) | $1.22B |
| Gross Profit (TTM) | $809.63M |
| EBITDA | $330.54M |
| Operating Margin | 19.70% |
| Return on Equity | 3.97% |
| Return on Assets | 6.52% |
| Revenue/Share (TTM) | $7.79 |
| Book Value | $12.90 |
| Price-to-Book | 4.29 |
| Price-to-Sales (TTM) | 6.89 |
| EV/Revenue | 7.24 |
| EV/EBITDA | 38.73 |
| Quarterly Earnings Growth (YoY) | 9.10% |
| Quarterly Revenue Growth (YoY) | -0.40% |
| Shares Outstanding | $156.45M |
| Float | $154.56M |
| % Insiders | 0.30% |
| % Institutions | 113.02% |
Historical Volatility
HV 10-Day
70.60%
HV 20-Day
54.32%
HV 30-Day
45.95%
HV 60-Day
47.00%
HV Rank
65.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($72.27 target)
1
Strong Buy9
Buy4
HoldData last updated: 4/29/2026